Grace Therapeutics Inc.

NASDAQ: GRCE · Real-Time Price · USD
3.26
0.18 (5.84%)
At close: Aug 15, 2025, 3:59 PM
3.26
0.02%
After-hours: Aug 15, 2025, 04:10 PM EDT

Grace Therapeutics Ratios and Metrics

Financials in USD. Fiscal year is April - March.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Mar 31, 2025 Mar 31, 2024 Mar 31, 2023 Mar 31, 2022
PE Ratio
-2.16 -1.74 -0.53 -1.88
PEG Ratio
0.04 0.02 -0.00 0.02
PS Ratio
n/a n/a n/a n/a
PB Ratio
0.41 0.36 0.33 0.17
P/FCF Ratio
-1.85 -1.81 -1.4 -1.07
P/OCF Ratio
-1.85 -1.81 -1.41 -1.07
OCF/S Ratio
n/a n/a n/a n/a
Debt / Equity Ratio
n/a n/a 0.01 0.00
Quick Ratio
11.77 14.26 8.59 13.89
Current Ratio
11.77 14.26 8.59 13.89
Asset Turnover
n/a n/a n/a n/a
Interest Coverage
n/a n/a n/a n/a
Return on Equity
-0.19 -0.21 -0.62 -0.09
Return on Assets
-0.18 -0.18 -0.54 -0.08
Return on Invested Capital
-0.18 -0.16 -0.56 -0.12
Dividend Yield
n/a n/a n/a n/a
Payout Ratio
n/a n/a n/a n/a
Gross Profit Margin
n/a n/a n/a n/a
Net Profit Margin
n/a n/a n/a n/a
Pretax Profit Margin
n/a n/a n/a n/a
Operating Profit Margin
n/a n/a n/a n/a
FCF Margin
n/a n/a n/a n/a
EBITDA Margin
n/a n/a n/a n/a